FM
GILD icon

Foster & Motley’s Gilead Sciences GILD Stock Holding History

Foster & Motley’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.77M Sell
12,702
-1,076
-8% -$151K 0.09% 177
2025
Q4 		$1.69M Sell
13,778
-301
-2% -$36.6K 0.09% 177
2025
Q3 		$1.56M Sell
14,079
-519
-4% -$59K 0.08% 191
2025
Q2 		$1.62M Sell
14,598
-58
-0.4% -$6.17K 0.09% 188
2025
Q1 		$1.64M Buy
14,656
+4,069
+38% +$420K 0.1% 175
2024
Q4 		$978K Buy
10,587
+4,718
+80% +$425K 0.06% 214
2024
Q3 		$492K Sell
5,869
-138
-2% -$10.5K 0.03% 281
2024
Q2 		$412K Buy
6,007
+53
+0.9% +$3.54K 0.03% 291
2024
Q1 		$436K Buy
5,954
+137
+2% +$10.5K 0.03% 279
2023
Q4 		$471K Buy
5,817
+13
+0.2% +$1.01K 0.04% 270
2023
Q3 		$435K Buy
5,804
+63
+1% +$4.85K 0.04% 283
2023
Q2 		$442K Sell
5,741
-107
-2% -$8.53K 0.03% 302
2023
Q1 		$485K Buy
5,848
+153
+3% +$12.7K 0.04% 284
2022
Q4 		$489K Sell
5,695
-377
-6% -$29.9K 0.04% 281
2022
Q3 		$375K Buy
6,072
+70
+1% +$4.41K 0.04% 283
2022
Q2 		$371K Sell
6,002
-299
-5% -$18.5K 0.03% 283
2022
Q1 		$375K Sell
6,301
-255
-4% -$16.3K 0.03% 283
2021
Q4 		$476K Sell
6,556
-107
-2% -$7.37K 0.04% 256
2021
Q3 		$465K Sell
6,663
-1,419
-18% -$99.7K 0.04% 240
2021
Q2 		$557K Buy
8,082
+1,675
+26% +$112K 0.05% 223
2021
Q1 		$414K Hold
6,407
– – 0.03% 239
2020
Q4 		$373K Buy
6,407
+653
+11% +$39.4K 0.04% 235
2020
Q3 		$364K Buy
5,754
+3
+0.1% +$208 0.04% 212
2020
Q2 		$442K Buy
5,751
+2
+0% +$153 0.06% 196
2020
Q1 		$430K Sell
5,749
-295
-5% -$20.4K 0.06% 184
2019
Q4 		$393K Sell
6,044
-162
-3% -$10.6K 0.05% 210
2019
Q3 		$393K Buy
6,206
+2
+0% +$131 0.05% 200
2019
Q2 		$419K Sell
6,204
-499
-7% -$32.8K 0.06% 196
2019
Q1 		$436K Buy
6,703
+2
+0% +$133 0.06% 187
2018
Q4 		$419K Sell
6,701
-103
-2% -$7.2K 0.07% 180
2018
Q3 		$525K Sell
6,804
-486
-7% -$36.7K 0.08% 169
2018
Q2 		$516K Sell
7,290
-113
-2% -$7.98K 0.08% 162
2018
Q1 		$558K Sell
7,403
-1,068
-13% -$84.9K 0.09% 150
2017
Q4 		$607K Sell
8,471
-108
-1% -$8.2K 0.1% 147
2017
Q3 		$695K Sell
8,579
-816
-9% -$62.4K 0.12% 131
2017
Q2 		$665K Sell
9,395
-498
-5% -$33.1K 0.12% 131
2017
Q1 		$672K Sell
9,893
-2,265
-19% -$159K 0.12% 125
2016
Q4 		$871K Sell
12,158
-6,706
-36% -$498K 0.17% 113
2016
Q3 		$1.49M Sell
18,864
-48,483
-72% -$3.94M 0.29% 93
2016
Q2 		$5.62M Sell
67,347
-5,785
-8% -$513K 1.11% 34
2016
Q1 		$6.72M Sell
73,132
-561
-0.8% -$50.6K 1.36% 25
2015
Q4 		$7.46M Buy
73,693
+2,477
+3% +$258K 1.58% 17
2015
Q3 		$6.98M Buy
71,216
+9,493
+15% +$1.05M 1.59% 16
2015
Q2 		$7.23M Buy
61,723
+18,874
+44% +$2.06M 1.59% 17
2015
Q1 		$4.21M Buy
42,849
+8,579
+25% +$871K 0.92% 40
2014
Q4 		$3.23M Buy
34,270
+20,585
+150% +$2.13M 0.73% 46
2014
Q3 		$1.46M Buy
13,685
+10,388
+315% +$1.02M 0.34% 82
2014
Q2 		$273K Buy
+3,297
New +$257K 0.06% 147

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Foster & Motley's GILD Position: Q1 2026 in Review

Foster & Motley reduced its Gilead Sciences (GILD) stake by 7.8% in Q1 2026, selling an estimated $151K and leaving 12,702 shares worth $1.77M. The position accounts for 0.09% of the portfolio, ranked #177.

Foster & Motley first reported a position in GILD in Q2 2014 and has held it in 48 quarters since. The position peaked at $7.46M in Q4 2015. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Foster & Motley held 12,702 shares of Gilead Sciences worth $1.77M as of Q1 2026.
  • Foster & Motley sold 1,076 Gilead Sciences shares in Q1 2026, an estimated $151K.
  • Gilead Sciences made up 0.09% of Foster & Motley's portfolio in Q1 2026, its #177 holding.
  • Foster & Motley first reported a position in Gilead Sciences in Q2 2014 and has held it in 48 quarters since.
  • Foster & Motley's Gilead Sciences position peaked at $7.46M in Q4 2015.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Foster & Motley's 13F filing for Q1 2026, filed 21 Apr 2026.